List of Excipients in API carbinoxamine maleate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing carbinoxamine maleate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Aytu Therapeutics LLC | KARBINAL | carbinoxamine maleate | 23594-101 | ANHYDROUS CITRIC ACID | |
| Aytu Therapeutics LLC | KARBINAL | carbinoxamine maleate | 23594-101 | GLYCERIN | |
| Aytu Therapeutics LLC | KARBINAL | carbinoxamine maleate | 23594-101 | HIGH FRUCTOSE CORN SYRUP | |
| Aytu Therapeutics LLC | KARBINAL | carbinoxamine maleate | 23594-101 | METHYLPARABEN | |
| Aytu Therapeutics LLC | KARBINAL | carbinoxamine maleate | 23594-101 | POLYSORBATE 80 | |
| Aytu Therapeutics LLC | KARBINAL | carbinoxamine maleate | 23594-101 | POVIDONE | |
| Aytu Therapeutics LLC | KARBINAL | carbinoxamine maleate | 23594-101 | PROPYLPARABEN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing carbinoxamine maleate
Detailed excipient profiles for carbinoxamine maleate
Excipient focus: ANHYDROUS CITRIC ACID
carbinoxamine maleate drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Aytu Therapeutics LLC | carbinoxamine maleate | 23594-101 |
| Neos Therapeutics LP | carbinoxamine maleate | 62542-101 |
| Genus Lifesciences Inc | carbinoxamine maleate | 64950-243 |
| >Company | >Ingredient | >NDC |
carbinoxamine maleate drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: ANHYDROUS LACTOSE
carbinoxamine maleate drug variants containing ANHYDROUS LACTOSE
carbinoxamine maleate drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Aytu Therapeutics LLC | carbinoxamine maleate | 23594-101 |
| Neos Therapeutics LP | carbinoxamine maleate | 62542-101 |
| Genus Lifesciences Inc | carbinoxamine maleate | 64950-243 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
carbinoxamine maleate drug variants containing CELLULOSE, MICROCRYSTALLINE
carbinoxamine maleate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Aytu Therapeutics LLC | carbinoxamine maleate | 23594-101 |
| Neos Therapeutics LP | carbinoxamine maleate | 62542-101 |
| Genus Lifesciences Inc | carbinoxamine maleate | 64950-243 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
carbinoxamine maleate drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Aytu Therapeutics LLC | carbinoxamine maleate | 23594-101 |
| Neos Therapeutics LP | carbinoxamine maleate | 62542-101 |
| Genus Lifesciences Inc | carbinoxamine maleate | 64950-243 |
| >Company | >Ingredient | >NDC |
carbinoxamine maleate drug variants not containing GLYCERIN
Excipient focus: HIGH FRUCTOSE CORN SYRUP
carbinoxamine maleate drug variants containing HIGH FRUCTOSE CORN SYRUP
| Company | Ingredient | NDC |
|---|---|---|
| Aytu Therapeutics LLC | carbinoxamine maleate | 23594-101 |
| Neos Therapeutics LP | carbinoxamine maleate | 62542-101 |
| >Company | >Ingredient | >NDC |
carbinoxamine maleate drug variants not containing HIGH FRUCTOSE CORN SYRUP
Excipient focus: MAGNESIUM STEARATE
carbinoxamine maleate drug variants containing MAGNESIUM STEARATE
carbinoxamine maleate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Aytu Therapeutics LLC | carbinoxamine maleate | 23594-101 |
| Neos Therapeutics LP | carbinoxamine maleate | 62542-101 |
| Genus Lifesciences Inc | carbinoxamine maleate | 64950-243 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
carbinoxamine maleate drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Aytu Therapeutics LLC | carbinoxamine maleate | 23594-101 |
| Neos Therapeutics LP | carbinoxamine maleate | 62542-101 |
| Genus Lifesciences Inc | carbinoxamine maleate | 64950-243 |
| >Company | >Ingredient | >NDC |
carbinoxamine maleate drug variants not containing METHYLPARABEN
Excipient focus: POLYSORBATE 80
carbinoxamine maleate drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Aytu Therapeutics LLC | carbinoxamine maleate | 23594-101 |
| Neos Therapeutics LP | carbinoxamine maleate | 62542-101 |
| >Company | >Ingredient | >NDC |
carbinoxamine maleate drug variants not containing POLYSORBATE 80
Excipient focus: POVIDONE
carbinoxamine maleate drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Aytu Therapeutics LLC | carbinoxamine maleate | 23594-101 |
| Neos Therapeutics LP | carbinoxamine maleate | 62542-101 |
| >Company | >Ingredient | >NDC |
carbinoxamine maleate drug variants not containing POVIDONE
Excipient focus: PROPYLENE GLYCOL
carbinoxamine maleate drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Genus Lifesciences Inc | carbinoxamine maleate | 64950-243 |
| >Company | >Ingredient | >NDC |
carbinoxamine maleate drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
carbinoxamine maleate drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Aytu Therapeutics LLC | carbinoxamine maleate | 23594-101 |
| Neos Therapeutics LP | carbinoxamine maleate | 62542-101 |
| Genus Lifesciences Inc | carbinoxamine maleate | 64950-243 |
| >Company | >Ingredient | >NDC |
carbinoxamine maleate drug variants not containing PROPYLPARABEN
Excipient focus: SODIUM CITRATE
carbinoxamine maleate drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Genus Lifesciences Inc | carbinoxamine maleate | 64950-243 |
| >Company | >Ingredient | >NDC |
carbinoxamine maleate drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM METABISULFITE
carbinoxamine maleate drug variants containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Aytu Therapeutics LLC | carbinoxamine maleate | 23594-101 |
| Neos Therapeutics LP | carbinoxamine maleate | 62542-101 |
| >Company | >Ingredient | >NDC |
carbinoxamine maleate drug variants not containing SODIUM METABISULFITE
Excipient focus: SODIUM POLYSTYRENE SULFONATE
carbinoxamine maleate drug variants containing SODIUM POLYSTYRENE SULFONATE
| Company | Ingredient | NDC |
|---|---|---|
| Aytu Therapeutics LLC | carbinoxamine maleate | 23594-101 |
| Neos Therapeutics LP | carbinoxamine maleate | 62542-101 |
| >Company | >Ingredient | >NDC |
carbinoxamine maleate drug variants not containing SODIUM POLYSTYRENE SULFONATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN
carbinoxamine maleate drug variants containing SODIUM STARCH GLYCOLATE TYPE A CORN
| Company | Ingredient | NDC |
|---|---|---|
| Biocomp Pharma Inc | carbinoxamine maleate | 44523-825 |
| >Company | >Ingredient | >NDC |
carbinoxamine maleate drug variants not containing SODIUM STARCH GLYCOLATE TYPE A CORN
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
carbinoxamine maleate drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
carbinoxamine maleate drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Aytu Therapeutics LLC | carbinoxamine maleate | 23594-101 |
| Biocomp Pharma Inc | carbinoxamine maleate | 44523-825 |
| Neos Therapeutics LP | carbinoxamine maleate | 62542-101 |
| Genus Lifesciences Inc | carbinoxamine maleate | 64950-243 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
carbinoxamine maleate drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Genus Lifesciences Inc | carbinoxamine maleate | 64950-243 |
| >Company | >Ingredient | >NDC |
carbinoxamine maleate drug variants not containing SORBITOL
Excipient focus: SUCROSE
carbinoxamine maleate drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Aytu Therapeutics LLC | carbinoxamine maleate | 23594-101 |
| Neos Therapeutics LP | carbinoxamine maleate | 62542-101 |
| >Company | >Ingredient | >NDC |
carbinoxamine maleate drug variants not containing SUCROSE
Excipient focus: TRIACETIN
carbinoxamine maleate drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Aytu Therapeutics LLC | carbinoxamine maleate | 23594-101 |
| Neos Therapeutics LP | carbinoxamine maleate | 62542-101 |
| >Company | >Ingredient | >NDC |
carbinoxamine maleate drug variants not containing TRIACETIN
Excipient focus: WATER
carbinoxamine maleate drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Aytu Therapeutics LLC | carbinoxamine maleate | 23594-101 |
| Neos Therapeutics LP | carbinoxamine maleate | 62542-101 |
| Genus Lifesciences Inc | carbinoxamine maleate | 64950-243 |
| >Company | >Ingredient | >NDC |
carbinoxamine maleate drug variants not containing WATER
Excipient focus: XANTHAN GUM
carbinoxamine maleate drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Aytu Therapeutics LLC | carbinoxamine maleate | 23594-101 |
| Neos Therapeutics LP | carbinoxamine maleate | 62542-101 |
| >Company | >Ingredient | >NDC |
carbinoxamine maleate drug variants not containing XANTHAN GUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
